TOP HEADLINES
- Final results from Pfizer BioNtech vaccine trial show it had a 95 percent success rate and two months of safety data, meaning the drugmaker can soon apply for use in an emergency authorization.
- Most of the Netherlands' current lockdown measures must remain in place until at least mid-December, despite a 15 percent drop in new cases, Prime Minister Mark Rutte has announced.
- Hungary vetoed the European Union's post-coronavirus recovery fund because it "attempts to blackmail countries which oppose migration," claims Prime Minister Viktor Orban.
- France's total number of cases now exceeds 2 million but according to its top health official, lockdown measures are starting "to bear fruit."
- State auditors have criticized the UK government for a lack of transparency over handing out $24 billion in coronavirus contracts as ministers refute claims they are running a "chumocracy."
- Denmark's agriculture minister has resigned amid backlash over the government's decision to order the cull of all farmed mink to prevent the spread of the coronavirus, despite not having the legal authority to do so.
- Portugal has set up a taskforce for developing a vaccination strategy, with the health ministry hopeful of being able to distribute shots as early as January.
- A third health chief in the southern Italian region of Calabria has quit in barely a week, leaving the coronavirus "red-zone" without anyone to steer its emergency coronavirus plan.
- Police have clashed with protesters in Berlin during mass demonstrations against new legal framework for enforcing coronavirus restrictions in Germany.
- British Airways and American Airlines are set to launch a virus testing trial this month in the hope of convincing the U.S. and UK governments to introduce testing so that transatlantic travel can restart.
- Poland has reported a record 603 new coronavirus-related deaths in the past 24 hours, despite optimism over a fall in new infections since restrictions were tightened.
France's total number of cases now exceeds 2 million. /Jeff Pachoud/AFP
France's total number of cases now exceeds 2 million. /Jeff Pachoud/AFP
AROUND EUROPE
Ross Cullen in Paris
France has passed the 2 million cases mark, only three weeks after it became the second European country to break the 1 million threshold.
However, the director of public health says the R rate, the reproduction rate for how many people a person with COVID-19 infects, is below one. There have also been seven consecutive days of a falling rate of transmission.
President Emmanuel Macron is going to speak next week about how and when France will exit lockdown. It is likely he will announce a gradual easing of measures rather than a whole-scale lifting of lockdown.
In other news, the government's anti-fraud watchdog has warned that 13 percent of antiseptic hand gels sold in France are ineffective.
Lucy Hough in Brussels
Belgium's bars and restaurants are unlikely to reopen this year, according to biostatistician Neil Hens, as discussions get under way about the end of the new lockdown.
With pubs and restaurants known to be a "high-risk environment," Hens said they were likely to remain closed until spring 2021.
It comes as the number of coronavirus infections in Belgium is continuing to drop, with an average of 4,804.9 new people testing positive for the virus in the past week. This marks a decrease of 39 percent from the week before.
There were an average 478 daily hospitalizations, a decrease of 22 percent. The death toll has also started to decrease, with 184 per day.
00:20
Linda Kennedy in Budapest
Hungary's police have taken action against 358 people in the past 24 hours for violating the curfew imposed to reduce the spread of the coronavirus.
Meanwhile, samples of Russia's Sputnik vaccine are expected to arrive in Hungary soon.
Prime Minister Viktor Orban, who rarely gives interviews, but does speak to state radio every Friday, was asked if the Russian vaccine would be perceived by the Hungarian population as safe to take.
He insisted vaccinations would not be compulsory, and individuals would be able to select from various vaccines, from the U.S. and from Russia and China. "People will decide. Everyone will decide which one they trust," he said.
FROM OUR GLOBAL COLLEAGUES
CGTN Europe special: The Alps: Timeless and changing
CGTN China: China's Sinovac COVID-19 vaccine induces quick antibody responses: study
CGTN America: How Pfizer’s genetic vaccine works against COVID-19
CGTN Africa: Africa's confirmed COVID-19 cases close to 1.98 million, Africa CDC
Sign up here to get the COVID-19 Europe bulletin sent directly to your inbox
CGTN Europe has been providing in-depth coverage of the novel coronavirus story as it has unfolded. Here you can read the essential information about the crisis.
Source(s): Reuters
,AFP